Symposium:
82. HIV and Tuberculosis: Twin Epidemics
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 253ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the potential to prevent TB in HIV-infected persons through early access to ART and lsoniazid preventive therapy
  • cite breakthroughs in TB diagnostics with particular relevance for HIV-infected persons with smear negative
  • review their expertise in the clinical management of co-infected individuals

Target Audience: Researchers, Public Health Practitioners, Pharmacists, Infectious Diseases Physicians, HIV Clinicians, Health Care Workers, Clinicians

Tracks: Global ID, HIV

Moderator:  Rochelle Walensky, MD, MPH, FIDSA, Massachusetts General Hospital

Presentations:

2:15 PM
737
View from the Epicenter
Helen Ayles, PhD

2:45 PM
738

3:15 PM
739

3:45 PM
740
Diagnostics for HIV-associated TB
Stephen D. Lawn, MD, DTMH

CME Credits: Maximum of 2.0 hours of Category 1 credit possible

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-145-L02-P

Disclosures:

R. Walensky, None

H. Ayles, Delft Diagnostic Imaging: Grant Investigator, Research support
Glaxo Smith Kline: Scientific Advisor, Speaker honorarium

B. Durovni, None

D. Fitzgerald, None

S. D. Lawn, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.